Medigen Biotechnology Corporation
Clinical trials sponsored by Medigen Biotechnology Corporation, explained in plain language.
-
Immune cells aim to prevent colon cancer return in Early-Stage patients
Disease control Recruiting nowThis early-phase study tests a new treatment called Magicell-NK for people with stage I or IIa colon cancer who have had surgery to remove the tumor. The treatment uses the patient's own natural killer (NK) cells, which are grown in a lab and then infused back into the body to he…
Phase: PHASE1 • Sponsor: Medigen Biotechnology Corporation • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Immune cell boost after surgery may keep pancreatic cancer at bay
Disease control Recruiting nowThis study tests whether adding donated natural killer (NK) immune cells to standard chemotherapy can help prevent cancer from coming back after surgery for pancreatic or bile duct cancer. About 42 adults who had their tumor removed will receive either chemo alone or chemo plus N…
Phase: PHASE1, PHASE2 • Sponsor: Medigen Biotechnology Corporation • Aim: Disease control
Last updated May 14, 2026 12:04 UTC